Skip Navigation
Skip to contents

Anat Cell Biol.  2011 Sep;44(3):204-209. 10.5115/acb.2011.44.3.204.

Vitamin D3 regulates cell viability in gastric cancer and cholangiocarcinoma

Affiliations
  • 1Department of Anatomy, Pusan National University School of Medicine, Yangsan, Korea. hedgehog@pusan.ac.kr
  • 2Medical Research Center for Ischemic Tissue Regeneration, Pusan National University School of Medicine, Yangsan, Korea.

Abstract

A low serum level of vitamin D has been associated with an increased incidence of gastrointestinal tract cancers. However, the effects of vitamin D3 have not been investigated in gastric cancer and cholangiocarcinoma. In the present study, we found that vitamin D3 treatment significantly suppressed the viability of gastric cancer and cholangiocarcinoma cells. Moreover, vitamin D3 had a synergistic effect with other anti-cancer drugs, such as paclitaxel, adriamycin, and vinblastine, for suppressing cell viability. To determine the underlying mechanism involved in the regulation of viability by vitamin D3, we examined the effects of vitamin D3 on expression of hedgehog signaling target genes, which has been associated with gastric cancer and cholangiocarcinoma. Vitamin D3 treatment decreased the level of mRNA expression of patched1, Gli1, cyclin D1, and Bcl2, suggesting the possibility that vitamin D3 may act through regulation of hedgehog signaling. From the above results, we conclude that vitamin D3 regulates cell viability in gastric cancer and cholangiocarcinoma.

Keyword

Cholecalciferol; Stomach neoplasms; Cholangiocarcinoma

MeSH Terms

Cell Survival
Cholangiocarcinoma
Cholecalciferol
Cyclin D1
Doxorubicin
Gastrointestinal Neoplasms
Hedgehogs
Incidence
Paclitaxel
RNA, Messenger
Stomach Neoplasms
Vinblastine
Vitamin D
Vitamins
Cholecalciferol
Cyclin D1
Doxorubicin
Paclitaxel
RNA, Messenger
Vinblastine
Vitamin D
Vitamins
Full Text Links
  • ACB
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr